Innovating Works

ARIVIS AG

Desconocido
DESIREE: Decision Support and Information Management System for Breast Cancer ARIVIS AG participó en un H2020 H2020-PHC-2014-2015 Breast cancer is the most common type of cancer affecting woman in the EU. Multidisciplinary Breast Units (BUs) were introduced in order to...
2015-11-10 - 2019-07-31 | Financiado
Phd: Deciphering PI3K biology in health and disease ARIVIS AG participó en un H2020 H2020-MSCA-ITN-2015 The Phosphoinositide 3-kinase (PI3K) pathway is at the core of multiple fundamental biological processes controlling metabolism, protein syn...
2015-08-07 - 2019-10-31 | Financiado
RELEVANCE: Regulation of red cell life span erythropoiesis survival senescence and clearance ARIVIS AG participó en un H2020 H2020-MSCA-ITN-2015 Anaemia is the most common pathological condition affecting 1.6 billion individuals worldwide. It thus presents a serious health care proble...
2015-08-03 - 2019-11-30 | Financiado
COMMITMENT: Combined Molecular Microscopy for Therapy and Personalized Medication in Rare Anaemias Treatments ARIVIS AG participó en un FP7 The aim of CoMMiTMenT is the development of combined imaging technologies based on optofluidic microscopy and scanning ion conductance micro...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.